---
title: Research Vision
subtitle: Bridging Physics and Biology Through Integrated Platforms
---

## ğŸ¯ Integrative Research

![Integration Concept](/images/research/integration-concept.png)

**Core Innovation:** Using nanofluidic confinement to bridge cellular complexity 
and molecular precision.

**Why This Matters:**
- Traditional *in vitro* studies: molecular precision âœ“, but not physiological âœ—
- *In vivo* studies: physiological âœ“, but no quantitative mechanisms âœ—
- **Our approach:** Both âœ“âœ“

---

## ğŸ”¬ Intergrated Platform

![Integration Concept](/images/research/technical-platform.png)

**Three Integrated Components:**

1. **Single-Molecule Imaging (TIRF)**
   - Real-time observation at molecular resolution
   
2. **Nano/Microfluidic Control**
   - Systematic tuning: confinement (50 nm - 2 Î¼m) + crowding (0-400 mg/mL)
   
3. **Multi-Protein Systems**
   - Direct competition dynamics under physiological conditions

---

## ğŸ“ Current Focus: RecA as Model System

**Why RecA First:**
- Validates platform capabilities
- Establishes quantitative framework
- Reveals unexpected RNA discrimination mechanism

**Key Insight:** [ç°¡çŸ­ä¸€å¥è©±ï¼Œä¾‹å¦‚ï¼šRecA distinguishes DNA vs RNA 
through distinct biophysical mechanisms]

---

## ğŸ¯ Target Application: p53-Chromatin Competition

**The Biological Question:**
How does p53 access its binding sites when DNA is wrapped around histones?

**Why Existing Methods Can't Answer This:**
- Bulk biochemistry: loses single-molecule events
- Dilute conditions: 10-100Ã— less crowded than cells
- No spatial constraint control

**Our Approach:**
Systematically measure how crowding AND confinement affect competitive 
binding equilibrium

**Potential Impact:**
- **Fundamental:** Physics of competitive protein-DNA binding
- **Translational:** Screen compounds that enhance p53 access â†’ cancer therapeutics

---

## ğŸ’¡ Why This Research Matters

| Aspect | Contribution |
|--------|-------------|
| **Fundamental Science** | New physical principles governing competitive binding under physiological constraints |
| **Methodology** | Generalizable platform for any protein-DNA competition system |
| **Translation** | Drug screening for chromatin-targeting cancer therapies |

---

<div style="background-color: #f0f0f0; padding: 20px; border-left: 4px solid #007acc;">
<strong>ğŸ“š Interdisciplinary Foundation:</strong> This work integrates polymer 
physics, microfluidic engineering, and molecular biology. See <a href="/research/trajectory">Research Trajectory</a> for 
the full story.
</div>